Subacute posttraumatic ascending myelopathy: a literature review

J Zhang1, G Wang2

  • 1Department of Orthopedic Surgery, Tianjin Baodi Hospital, Tianjin, China.

Spinal Cord
|December 21, 2016
PubMed
Abstract

Insights

Subacute posttraumatic ascending myelopathy (SPAM) is a rare complication of spinal cord injury (SCI). Currently, there is no effective treatment, and the prognosis is poor, with a 10% mortality rate.

Area of Science:

  • Neurology
  • Neurosurgery
  • Spinal Cord Injury Research

Background:

  • Subacute posttraumatic ascending myelopathy (SPAM) is a rare but serious neurological complication following spinal cord injury (SCI).
  • Understanding the history, epidemiology, and pathophysiology of SPAM is crucial for improving patient outcomes.
  • This condition presents unique diagnostic and therapeutic challenges.

Purpose of the Study:

  • To comprehensively review the existing literature on SPAM.
  • To summarize the history, epidemiology, etiology, pathology, clinical and radiological features, treatment, and prognosis of SPAM.
  • To provide a consolidated resource for clinicians and researchers investigating this rare disorder.

Main Methods:

  • A systematic literature review was conducted using major medical databases (PubMed, Medline, Ovid, Embase).
  • Cases of SPAM reported in the literature were analyzed.
  • Key aspects including history, epidemiology, etiology, pathology, clinical presentation, radiological findings, treatment strategies, and prognosis were extracted and summarized.

Main Results:

  • SPAM is a rare disorder, occurring in 0.42% to 1% of SCI cases, typically within weeks of injury.
  • Young to middle-aged males are more commonly affected. Risk factors include complete SCI, hypotension, early mobilization, and non-surgical management.
  • SPAM is characterized by specific clinical and MRI findings.

Conclusions:

  • SPAM is recognizable through clinical and MRI characteristics.
  • Currently, no effective therapies exist for this neurological deterioration, leading to a poor prognosis.
  • While some minor improvement below the maximal deterioration level may occur, the mortality rate is approximately 10%.

Related Concept Videos